Trace Sensing Technologies


Develops breath-based diagnostic technology using ultra-sensitive vapor sensors to detect proteomic and volatile organic compound (VOC) biomarkers in exhaled breath. The company designs compact desktop diagnostic devices and accompanying software, conducts biomarker discovery and validation studies across cardiometabolic, neurodegenerative, oncology and infectious disease areas, and maintains a patent portfolio for its sensor technology. It is pursuing regulatory authorization and clinical pilots to enable point-of-care deployment.

Industries

biotechnology
real-time
sensor

Nr. of Employees

small (1-50)

Trace Sensing Technologies

Wallingford, Connecticut, United States, North America


Products

Desktop breath-analysis diagnostic device

A compact desktop device that analyzes exhaled breath using configurable sensor modules and catalyst-coated vapor sensors to detect biomarkers and deliver rapid test results.


Services

Biomarker discovery and validation partnerships

Collaborative studies with academic and clinical partners to discover and validate breath biomarkers across disease indications.

Pilot study and clinical evaluation support

Operational support and device access for pilot studies evaluating breath-based diagnostics in target populations (examples: CKD, ADRD, cancer, infectious disease).

Expertise Areas

  • Breath diagnostics and VOC analysis
  • Sensor engineering and catalyst tuning
  • Biomarker discovery and validation
  • Point-of-care diagnostic device development
  • Show More (4)

Key Technologies

  • Breath biomarker analysis (proteins and VOCs)
  • Microheater-based vapor sensors
  • Catalyst-coated thin-film sensors
  • Metal-oxide catalyst sensing
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.